Potential adherence to treatment in gastroenterological patients

Objective. To assess the level of potential adherence to treatment in patients with gastrointestinal syndromes.

Material and Methods. The open-label, cross- sectional study included 264 respondents who underwent preventive examinations. To identify gastroenterological syndromes we used Gastrointestinal Simptom Rating Scale (GSRS) questionnaire, which allows assessing the presence and the intensity of diarrheal, dyspeptic, constipation, refl ux syndrome and abdominal pain syndrome. The study group includes respondents who, according to the results of the GSRS questionnaire, have at least one syndrome (from 2 or more points) (N = 140). The comparison group included participants without gastrointestinal syndromes (N = 124). The level of adherence was assessed using the Quantitative Adherence Assessment Questionnaire (QAA-25). A score of less than 50% corresponds to a low level of adherence; a score between 50% and 75% corresponds to a medium level of adherence. Of 75% and above is considered to be a high and suffi cient level of adherence in the respondent.

Results. Absolutely all respondents demonstrated an insuffi cient level of adherence to both drug therapy and medical support and lifestyle modifi cations. One in ten study participants had an medium level of adherence. The other 90% of patients from all groups had a low level of compliance (less than 50%) in all three areas of treatment adherence.

Conclusions. Participants in our study were potentially unprepared for adherence to treatment that is consistent with optimal protocols. This demonstrates the need to work with adherence, both using ways to increase adherence and using patientcentered approaches that take into account the individual level of adherence.

1. World Health Organization. Adherence to longterm therapies: evidence for action. WHO Library Cataloguing-in- Publication Data, Geneva, WHO 2003. 211 р. Available at https://www.who. int/chp/knowledge/ publications/adherence_report/en/.

2. Simpson S. H., Eurich D. T., Ma- jumbar S.R., et al. A meta- analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15–8.

3. Martynov A. A., Spiridonova E. V. BMM. Increasing the adherence of inpatients and outpatient departments to treatment and rehabilitation programs and factors infl uencing compliance. Bulletin of Dermatology and Venereology. 2012; 21-7. (In Russ.)

4. Kane S., Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;1020–4.

5. Naletov A. V., Naletov S. V., Barinova A. S., Vyu nichen ko Yu. S. Th e problem of compliance in modern gastroenterology. University clinic. 2017; 13: 213-8. (In Russ.)

6. M. A. Livzan, “Nutritional behavior of students”, KMJ, no. 2, pp. 13–17, Jun. 2019. (in Russ.) Doi 10.26269/tvs8-by34

7. Livzan M. A.Pain syndrome in gastroenterology - therapy algorithm. Medical advice. 2010; 69–71. (In Russ.)

8. Kostenko M. B., Livzan M. A. Mechanisms of irritable bowel syndrome development. Siberian Journal of Gastroenterology and Hepatology. 2000; 32-5. (In Russ.)

9. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for themanagement of arterial hypertension. Eur. Heart J. Oxford University Press; 2018. pp. 3021–104.

10. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modifi cation to reduce cardiovascular risk. Eur. Heart J. Oxford University Press. 2020. pp. 111–88.

11. Collet J-P, Th iele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. Oxford University Press (OUP). 2021;42:1289–367.

12. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fi brillation developed in collaboration with the European Association of CardioTh oracic Surgery (EACTS). Eur Heart J. NLM (Medline). 2021;42:507.

13. Bunova SS, Zhernakova NI, Skirdenko YP, Nikolaev NA. Adherence to therapy, lifestyle modifi cation and medical support of cardiovascular patients. Cardiovasc Th er Prev (Russian). Vserossiiskoe Obshchestvo Kardiologov; 2020 [cited 2021 Apr 27];19:38–42. Available from: https:// cardiovascular.elpub.ru/jour/article/view/2665

14. Drapkina O, Livzan M, Martynov A, Moiseev C, Nikolaev N, Skirdenko Y. Th e fi rst russian expert consensus on the quantitative evaluation of the treatment adherence: pivotal issues, algorithms and recommendations. Med news North Caucasus. Stavropol State Medical University. 2018;13.

15. Livzan M. A., Krolevets T. S., Gaus O. V., Bikbavova G. R., Cherkashchenko N. A., Gorbenko A. V., Nikolaev N. A. diseases of the digestive system. Moscow. 2020. (In Russ.)

16. Fedorin MM, Gorbenko AV, Andreev KA, Okhot niko va PI, Demko IV, Skirdenko YP, et al. Medical background and potential adherence to treatment – solid cross- sectional surprises. Profi l meditsina. 2020;23:15.

17. Drapkina O. M., Livzan M. A., Martynov A. I., Moiseev S. V., Nikolaev N. A., Skirdenko Yu. P. Th e fi rst Russian consensus on quantifying adherence to treatment: main provisions , algorithms and recommendations. Medical Bulletin of the North Caucasus. 2018; 13: 259-71. (In Russ.)

18. Nikolaev N. A., Martynov A. I., Skirdenko Yu. P. et al. Management of treatment on the basis of adherence. Consensus document – Clinical recommendations. RSMSIM, SSGR, NATH, SEBN, GS RAS, RSH, RSP. Consilium Medicum. 2020; 22 (5): 9–18. (In Russ.) DOI: 10.26442/20751753.2020.5.200078

19. Nikolaev N. A., Martynov A. I., Skirdenko Yu. P., Anisimov V. N., Vasilieva I. A. et al. Treatment management based on adherence: patient recommendation algorithms. Cross-disciplinary guidelines. Medical News of North Caucasus. 2020;15(4):461-468. (In Russ.) DOI: 10.14300/mnnc.2020.15109

20. Kulich K. R., Madisch A., Pacini F., Piqué J. M., Regula J., Van Rensburg C. J., Ujszászy L., Carlsson J., Halling K., Wiklund I. K. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Refl ux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Heal Qual Life Outcomes. 2008;31:12.